AxoGen, Inc.(AXGN)- NASDAQ
  • wilkinson99 | Send Message 4 Aug

    Top % Gainers: $CHEK 75%, $OCUL 28%, $IL 27%, $AXGN 21%, $PCRX 19%, $XPO 17%, $PODD 16%, $SQ 15%, $MITL $ERII $PTX $CPA $TK $MX $EXEL $GDDY
    Reply
      • timtrading | Send Message 6 Oct 2015

        bullish engulfing pattern $AXGN,$MX http://bit.ly/1aT1pSL
        Reply
          • Cockrell Group | Send Message 4 May 2015

            AxoGen, Inc. $AXGN CEO Karen Zaderej, expected to appear on FOX Business' "After the Bell" with Liz Claman today at 4PM ET
            Reply
              • Tedra DeSue | Send Message 17 Nov 2014

                This Biotech Micro Cap Is Undervalued; Primed To Buy $PDLI, $AXGN http://seekingalpha.com/p/22b5z
                Reply
                  • snakepitt1 | Send Message 31 Dec 2013

                    $AXGN Nerve regeneration process that is proven to work. Stock will skyrocket once company receives more press. Helping veterans right now
                    Reply
                      • Cockrell Group | Send Message 3 Dec 2013

                        $AXGN CEO, Karen Zaderej to appear on Bloomberg TV tonight @ 5:10 PM
                        Reply
                          • Cockrell Group | Send Message 30 Oct 2013

                            $AXGN (Px tgt: $5.75) to release results today after close. Analysts expect 3Q13 Revs of $3 million vs. $2 million in 3Q12.
                            Reply
                              • Cockrell Group | Send Message 9 Aug 2013

                                $AXGN completed $18 Million underwritten offering at a price of $3.00 per share.
                                Reply
                                  • Cockrell Group | Send Message 9 Aug 2013

                                    $AXGN shares UPLISTED to NASDAQ under symbol AXGN
                                    Reply
                                      • Cockrell Group | Send Message 18 Apr 2013

                                        JMP Securities initiates coverage on $AXGN shares with an OUTPERFORM rating and an $8.00 share price.
                                        Reply
                                          Company Description
                                          AxoGen, Inc. is a regenerative medicine company, which is focused on the science, development and commercialization of technologies for peripheral nerve solutions. The company's products include Avance Nerve Graft, AxoGuard Nerve Protector and AxoGuard Nerve Connector. The company was founded in... More
                                          Sector: Healthcare
                                          Industry: Medical Appliances & Equipment
                                          Country: United States